This Monday, United States health officials reported that they are in the process of releasing some doses of the Jynneos vaccine for use in cases of monkeypox.
The information was shared by the Centers for Disease Control and Prevention (CDC). They also said that there are more than 1,000 dose in the national reserve.
CDC experts also explained that the level may increase rapidly in the coming weeks, he reviewed. The nation.
Monkeypox and its lethality
The professor of microbiology at the University of Salamanca in Spain, Raúl Rivas, explained to the BBC Worldthat «Fortunately, monkeypox is much milder than the larger version of human smallpox, which reached 30%».
He also explained that the one presented in “West Africa is the mildest, with a mortality of between 1% and 10%, and it seems to be the one that is causing the outbreak in Europe.”
While the one from “Central Africa, on the other hand, is more virulent and dangerous and can kill around 20% of those infected,” he added.
Incubation period
The highest lethality, according to the data collected, occurs in zones very poor rural Africa. As well as generally in children, because they have a less developed immune system.
In addition to the outbreaks of blisters, the symptoms also include swelling of the lymph nodes, both cervical, maxillary, axillary and in the groin.
For its part, the incubation period is usually 7 to 14 days, but can be reduced to 5 and raised to 21 days.
